“It is a very serious disease with serious complications from which patients die relatively young,” says hematologist Linet Njue, senior physician at Inselspital Bern. According to the doctor, around 100 patients with the disease are being treated in large university hospitals in Switzerland, but the exact number is not recorded. It is one of the most common hereditary diseases worldwide.
The disease is caused by a gene that carries the blueprint for the red blood pigment haemoglobin. A gene mutation crystallizes the hemoglobin, causing the normally round red blood cells to deform into sickles. These, in turn, clog the bloodstream.
Now, the UK Medicines Agency has given the green light for a new gene therapy for sickle cell anaemia patients aged 12 and over. It is called Exacel (brand name “Casgevy”) and was developed by the companies Vertex Pharmaceuticals and CRISPR Therapeutics, the latter based in Zug.
It is the first ever approved treatment based on the CRISPR/Cas9 gene scissors. This is the technology that can precisely cut through and modify the genetic material and for the discovery of which the Nobel Prize in Chemistry was awarded in 2020.
No need for a foreign donor anymore
Victoria Gray, now 37, was the first person to be treated with the therapy in 2019. Thanks to the new “supercells”, her life has changed completely, she recently said. She now lives free of pain, can go back to work and take care of her four children.
Exacel has now been tested on around forty sickle cell anemia patients. As Vertex Pharmaceuticals and CRISPR Therapeutics have announced, additional clinical trials with children between the ages of 2 and 11 are now to begin. An application for approval for the therapy has not yet been received from the companies in Switzerland, as Swissmedic confirmed on request.
How Exacel Therapy WorksExacel does not target the disease-causing and mutated HBB gene, which causes the sickle-shaped blood cells. Rather, the therapy is dedicated to the gene called BCL11A. This gene is activated at birth and thus inhibits the formation of haemoglobin, which is actually only produced in the fetus. Exacel then cuts BCL11A apart, which deactivates the gene again and resumes prenatal hemoglobin production. This provides additional hemoglobin that is not malformed. The symptoms of the disease disappear. (sny)
Jacob Corn is Professor of Genome Biology at ETH Zurich and has been working on CRISPR treatments for years, including for sickle cell disease. “The whole CRISPR community is in a frenzy. The Exacel successes are impressive,” he says.
Nevertheless, it is crucial to accompany the treated patients over a long period of time, the regulatory authorities require at least 15 years. This is the only way to rule out long-term side effects, such as an increased risk of blood cancer – a concern that worries some scientists. However, Corn emphasizes: “At the moment, things are looking really good.”
According to the ETH professor, the CRISPR gene scissors offer a gateway to a new world of medicine. He draws a comparison:
It’s the same with hereditary diseases so far: You can make a genetic diagnosis to suffering patients, but you can’t offer them a therapy – that’s changing now.
There are more than 7000,1 diseases that are based on a single gene mutation, such as sickle cell anemia, and dozens of therapies are already in the pipeline, for example against the metabolic disease called familial hypercholesterolemia, which affects about 200 in <> people in Switzerland.
Due to the disease, a dangerous amount of cholesterol always remains in the blood. This greatly increases the risk of a heart attack or stroke. Studies with the CRISPR therapy from the biotech company Verve Therapeutics have so far been promising, even suggesting that “the world’s biggest killer” can soon be stopped, according to the headline of the US magazine “MIT Technology Review”.
Targeting multiple genes is much more difficult
Other diseases in the focus of the genetic engineers are cystic fibrosis, Duchenne muscular dystrophy or progeria, in which affected children age as if in fast motion. In addition to these single-mutation diseases, there are countless other diseases that are based on a combination of several gene mutations and environmental factors: Alzheimer’s, arthritis, many cancers, diabetes, autism spectrum disorders are just a few examples.
Another hurdle of future CRISPR therapies is those diseases that affect organs that are difficult to reach. In sickle cell anemia, it is comparatively easy to extract the blood cells from the body, manipulate them and return them. “In cystic fibrosis, on the other hand, where the lungs are damaged, it is a much more difficult procedure to get the genetic medicine to the right place,” says Corn.
The high cost could limit availability
Geneticists are very worried about the horrendous costs, which are estimated to run into the millions for a single CRISPR treatment. It is questionable whether poorer countries can afford such therapies. Even rich countries get into trouble when a large number of patients suddenly want to be treated.
One dilemma, according to Jacob Corn, is that the safety requirements imposed by the health authorities are enormously high – and therefore costly. “That’s good, because it must be guaranteed that the therapies do no more harm than good.” The hope is that after the first approvals, the multitude of safety and efficacy tests will no longer have to be carried out every single time. “If the safety of CRISPR technology is proven on its own, then hopefully it would be legitimate to accelerate the testing and approval of therapies for other diseases,” says Corn.
Another approach: Instead of isolating the cells for the gene changes, treating them and then injecting them back into the body, researchers are tinkering with a gene injection: “The idea is that the genome editing process is injected into the body, so to speak, where it finds the right place and exerts its effect.” This would not only make treatment cheaper, but also more accessible, for example in regions of Africa where there are few health facilities. No tests have yet been carried out in humans, only in animals.
But Jacob Corn is confident: “A large number of research groups around the world are involved in CRISPR. How quickly things can sometimes happen when many bright minds are working on a problem at the same time was seen with the Corona vaccination.” (aargauerzeitung.ch)
News
Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
Researchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic processes behind Alzheimer’s disease, leading to potential new strategies for treatment. Alzheimer’s disease, the most common type of dementia, significantly impairs [...]
Cambridge Scientists Discover Simple “Twist” That Supercharges Clean Fuel Generation
Scientists have discovered a method to super-charge the ‘engine’ of sustainable fuel generation – by giving the materials a little twist. The researchers, led by the University of Cambridge, are developing low-cost light-harvesting semiconductors that power devices [...]
Completely New Use Discovered – This Traditional Herb Has Remarkable Nerve Regenerative Properties
Blessed thistle (Cnicus benedictus), a member of the Asteraceae family, thrives in our climate. This plant has been utilized for centuries as a medicinal herb, often consumed as an extract or tea to support [...]
Scientists study lipids cell by cell, making new cancer research possible
Imagine being able to look inside a single cancer cell and see how it communicates with its neighbors. Scientists are celebrating a new technique that lets them study the fatty contents of cancer cells, [...]
Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugs
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant worldwide challenge. A research group from China has [...]
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists clear a potential path toward earlier treatment for a disease that affects nearly 1,000,000 people in the United States. By Levi Gadye In a discovery that could hasten treatment for patients with multiple [...]
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
A study reveals that a new sequencing technique, tARC-seq, can accurately track mutations in SARS-CoV-2, providing insights into the rapid evolution and variant development of the virus. The SARS-CoV-2 virus that causes COVID has the unsettling [...]
No More Endless Boosters? Scientists Develop One-for-All Virus Vaccine
End of the line for endless boosters? Researchers at UC Riverside have developed a new vaccine approach using RNA that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised. Every [...]
How Are Hydrogels Shaping the Future of Biomedicine?
Hydrogels have gained widespread recognition and utilization in biomedical engineering, with their applications dating back to the 1960s when they were first used in contact lens production. Hydrogels are distinguished from other biomaterials in [...]
Nanovials method for immune cell screening uncovers receptors that target prostate cancer
A recent UCLA study demonstrates a new process for screening T cells, part of the body's natural defenses, for characteristics vital to the success of cell-based treatments. The method filters T cells based on [...]
New Research Reveals That Your Sense of Smell May Be Smarter Than You Think
A new study published in the Journal of Neuroscience indicates that the sense of smell is significantly influenced by cues from other senses, whereas the senses of sight and hearing are much less affected. A popular [...]
Deadly bacteria show thirst for human blood: the phenomenon of bacterial vampirism
Some of the world's deadliest bacteria seek out and feed on human blood, a newly-discovered phenomenon researchers are calling "bacterial vampirism." A team led by Washington State University researchers has found the bacteria are [...]
Organ Architects: The Remarkable Cells Shaping Our Development
Finding your way through the winding streets of certain cities can be a real challenge without a map. To orient ourselves, we rely on a variety of information, including digital maps on our phones, [...]
Novel hydrogel removes microplastics from water
Microplastics pose a great threat to human health. These tiny plastic debris can enter our bodies through the water we drink and increase the risk of illnesses. They are also an environmental hazard; found [...]
Researchers Discover New Origin of Deep Brain Waves
Understanding hippocampal activity could improve sleep and cognition therapies. Researchers from the University of California, Irvine’s biomedical engineering department have discovered a new origin for two essential brain waves—slow waves and sleep spindles—that are critical for [...]
The Lifelong Cost of Surviving COVID: Scientists Uncover Long-Term Effects
Many of the individuals released to long-term acute care facilities suffered from conditions that lasted for over a year. Researchers at UC San Francisco studied COVID-19 patients in the United States who survived some of the longest and [...]